These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 11708463)

  • 21. Optomechanical devices for deep plasma cancer proteomics.
    Kosaka PM; Calleja M; Tamayo J
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):26-38. PubMed ID: 28867489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE.
    Kondo T
    BMB Rep; 2008 Sep; 41(9):626-34. PubMed ID: 18823585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
    Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
    Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
    Fredolini C; Liotta LA; Petricoin EF
    Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Proteomic analysis of protein profiles in some pathological stages of the human organism].
    Kossowska B; Dudka I; Gancarz R; Antonowicz-Juchniewicz J
    Postepy Hig Med Dosw (Online); 2009 Nov; 63():549-63. PubMed ID: 19940332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laser capture microdissection in comparative proteomic analysis of hepatocellular carcinoma.
    Wang HY
    Methods Cell Biol; 2007; 82():689-707. PubMed ID: 17586277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures.
    Wright GL; Cazares LH; Leung SM; Nasim S; Adam BL; Yip TT; Schellhammer PF; Gong L; Vlahou A
    Prostate Cancer Prostatic Dis; 1999 Dec; 2(5-6):264-276. PubMed ID: 12497173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for the Analysis of Laser Capture Microdissected Fresh-Frozen Tissue Homogenates by Silver-Stained 1D SDS-PAGE.
    Prieto DA; Whitely G; Johann DJ; Blonder J
    Methods Mol Biol; 2018; 1723():95-110. PubMed ID: 29344855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laser capture microdissection and proteomics: possibilities and limitation.
    Craven RA; Banks RE
    Proteomics; 2001 Oct; 1(10):1200-4. PubMed ID: 11721632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
    Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
    Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers.
    Wiśniewski JR; Ostasiewicz P; Mann M
    J Proteome Res; 2011 Jul; 10(7):3040-9. PubMed ID: 21526778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innovative proteomic approaches for cancer biomarker discovery.
    Faca V; Krasnoselsky A; Hanash S
    Biotechniques; 2007 Sep; 43(3):279, 281-3, 285. PubMed ID: 17907570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
    Seibert V; Ebert MP; Buschmann T
    Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.